New, Chinese

New Chinese medicine drug developed by HKBU for myofibrillar myopathy granted orphan drug designation by FDA

Veröffentlicht: 07.08.2025 um 18:06 Uhr, prnewswire.co.uk

Hong Kong Baptist University Hong Kong United Kingdom

View original content:https://www.prnewswire.co.uk/news-releases/new-chinese-medicine-drug-developed-by-hkbu-for-myofibrillar-myopathy-granted-orphan-drug-designation-by-fda-302031050.html

en | boerse | 67950643 |